Is stopping GLP-1 permanently after weight loss recommended
Participants treated with Tirzepatide experienced an average weight loss of 15% to 20% of their initial body weight over the course of 72 weeks (approximately 16.5 months), which translated to an average weight loss of 34 lbs
Ensuring proper hydration, nutrition, and sleep can help mitigate this
The possible interaction of these medications with other drugs the patients were taking could also influence the outcomes
But attempts to maintain that weight loss can mean ongoing, possibly lifelong, injections which can prove costly, and much of the weight lost can be regained in a relatively short period of time if the medication is stopped
According to filed legal documents, they believe that Novo Nordisk should have included stronger warnings on its GLP-1 drugs labels